These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 29373131)
1. [Rheumatoid arthritis and polycythemia vera JAK2 negative association: Polycythemia may be worsening under methotrexate?]. Saidane O; Sellami M; Mahmoud I; Ben Tekaya A; Tekaya R; Abdelmoula L Therapie; 2018 Sep; 73(4):351-353. PubMed ID: 29373131 [No Abstract] [Full Text] [Related]
2. [2 years data of controlled trials with leflunomide vs. methotrexate and leflunomide vs. sulfasalazine]. Krüger K Z Rheumatol; 2002 Jun; 61(3):308-10. PubMed ID: 12219638 [No Abstract] [Full Text] [Related]
3. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate. O'Dell JR Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S53-8. PubMed ID: 10589358 [TBL] [Abstract][Full Text] [Related]
4. Therapies for active rheumatoid arthritis after methotrexate failure. O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E; N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969 [TBL] [Abstract][Full Text] [Related]
5. Is methotrexate oncogenic in patients with rheumatoid arthritis? Kremer JM Semin Arthritis Rheum; 1997 Jun; 26(6):785-7. PubMed ID: 9213376 [No Abstract] [Full Text] [Related]
6. [Cutaneous lymphoma associated with methotrexate in a patient with rheumatoid arthritis]. Antón Vázquez V; Corominas H; García Muñoz N; Hebe Petiti G Farm Hosp; 2018 Jan; 42(1):35-36. PubMed ID: 29306316 [No Abstract] [Full Text] [Related]
7. Angio-neurotic oedema associated with methotrexate treatment in rheumatoid arthritis. Freeman AM; Dasgupta B Rheumatology (Oxford); 1999 Sep; 38(9):908. PubMed ID: 10515658 [No Abstract] [Full Text] [Related]
8. Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice. Taniguchi A; Urano W; Tanaka E; Furihata S; Kamitsuji S; Inoue E; Yamanaka M; Yamanaka H; Kamatani N Pharmacogenet Genomics; 2007 Jun; 17(6):383-90. PubMed ID: 17502830 [TBL] [Abstract][Full Text] [Related]
9. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis. Shiroky JB J Rheumatol Suppl; 1996 Mar; 44():69-71. PubMed ID: 8833057 [TBL] [Abstract][Full Text] [Related]
10. The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis. Furst DE Clin Exp Rheumatol; 1999; 17(1):39-40. PubMed ID: 10084027 [No Abstract] [Full Text] [Related]
11. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study. Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I Ann Rheum Dis; 2007 Feb; 66(2):235-41. PubMed ID: 16926184 [TBL] [Abstract][Full Text] [Related]
12. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference? Dervieux T J Rheumatol; 2008 Apr; 35(4):550-2. PubMed ID: 18398948 [No Abstract] [Full Text] [Related]
14. Rheumatoid arthritis: Methotrexate and bridging glucocorticoids in early RA. Onuora S Nat Rev Rheumatol; 2014 Dec; 10(12):698. PubMed ID: 25385411 [No Abstract] [Full Text] [Related]
15. Treatment of rheumatoid arthritis. Zurier RB; DeMarco DM; Liu NY N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595 [No Abstract] [Full Text] [Related]
16. Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update. Ling SF; Bluett J Pharmacogenomics; 2020 Jan; 21(1):3-6. PubMed ID: 31849277 [No Abstract] [Full Text] [Related]
18. Radical Intervention in Early Rheumatoid Arthritis. The Case for Enteric-Coated Sulphasalazine, Methotrexate and Combination Regimes. Proceedings of a workshop. Camogli, Italy, September 1994. Br J Rheumatol; 1995 Nov; 34 Suppl 2():1-112. PubMed ID: 8535638 [No Abstract] [Full Text] [Related]
19. Two is better than one? Combination therapy in rheumatoid arthritis. Choy EH Rheumatology (Oxford); 2004 Oct; 43(10):1205-7. PubMed ID: 15226519 [No Abstract] [Full Text] [Related]
20. Nodulosis during methotrexate therapy for rheumatoid arthritis. Das SK; Kumar A J Assoc Physicians India; 1995 Sep; 43(9):651. PubMed ID: 8773077 [No Abstract] [Full Text] [Related] [Next] [New Search]